Trials / Completed
CompletedNCT05538728
An Open-label Study of Poly-l-lactic Acid for Correction of Wrinkles in the décolletage Area
A Prospective Open-label Study to Evaluate Safety and Effectiveness of Two Different Reconstitution Volumes of Poly-l-lactic Acid (PLLA) for Correction of Wrinkles in the décolletage Area
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- Female
- Age
- 22 Years
- Healthy volunteers
- Accepted
Summary
This is a prospective open-label study to evaluate safety and effectiveness of two different reconstitution volumes of poly-l-lactic acid (PLLA) for correction of wrinkles in the décolletage area.
Detailed description
A challenge for wrinkle correction of the decolletage/chest and other non-facial areas is that larger surface areas typically need to be treated than for facial indications, for which reason the Sponsor is investigating a larger reconstitution volume compared to the approved label. In this study, the total volume of 18mL, including 1mL of 2% lidocaine, is being explored and compared with results from the current labeled volume of 9mL, including lidocaine, to assess if the larger volume is well-tolerated for treatment for wrinkles in the decolletage area.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | poly-l-lactic acid (Sculptra) | Sculptra |
Timeline
- Start date
- 2022-08-31
- Primary completion
- 2023-08-08
- Completion
- 2023-08-08
- First posted
- 2022-09-14
- Last updated
- 2024-08-20
- Results posted
- 2024-08-20
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05538728. Inclusion in this directory is not an endorsement.